SIRPA and neoplasm: Tumor cells upregulate CD47 expression to evade phagocytosis, with CD47 acting as a ligand for three different receptors: signal regulatory protein alpha (SIRPα), thrombospondin-1 (TSP-1), and integrins, including αvβ3 and α2β1.